In learning of these statistics, we became convinced that there had to be other options for this desperate population and those that serve them. We at Nova Vita Care believe the time is now to offer Ketamine Infusion Therapy as a viable treatment option for the RGV.
Ketamine therapy has been hailed in Science magazine as the "biggest breakthrough in depression research in a half century" and has provided much-needed, effective relief to those with mental health conditions and suicidal thoughts. And according to Thomas Insel, Director for National Institute of Mental Health, "Recent data suggest that ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades.”
Ketamine was developed in 1963 by researchers from Wayne State University and FDA-approved in 1970 as an anesthetic and analgesic agent, and is now one of the most widely used drugs in modern medicine. It has been used safely in surgical settings, including pediatric surgery, and is now being utilized to manage acute and chronic pain conditions.
Ketamine infusion can now be effectively applied as an off-label treatment for various chronic, treatment-resistant mental health conditions, including depression, alcoholism, substance dependencies, PTSD, OCD, and other psychiatric diagnoses. Leading medical centers including the Mayo Clinic, Yale University, and Kaiser Permanente have launched ketamine clinics across the country and Nova Vita Wellness Centers are now bringing this incredibly effective and safe treatment to your patients.
- Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
- Ketamine for the treatment of addiction: Evidence and potential mechanisms
- Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review
- Administration of ketamine for unipolar and bipolar depression.
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression.
- A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
- Rapid Resolution of Suicidal Ideation after a Single Infusion of an NMDA Antagonist in Patients with Treatment-Resistant Major Depressive Disorder
- Ketamine as treatment for post-traumatic stress disorder: a review
- Science Magazine Research
- National Institute of Health Supported Research
- Cornell Medicine Research